BERBERIAN LANCE has filed 28 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 7668 shares of Privia Health Group, Inc. ($PRVA) on July 15, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 15, 2025 | Privia Health Group, Inc. | $PRVA | BERBERIAN LANCE | Director | A | Common Stock, $0.01 par value per share | 7668 | $0.00 | 7,668.0000 | 125,614,171 | 9999.99% | 0.01% |
| March 27, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | A | Common Stock | 3325 | $0.00 | 20,005.0000 | 83,400,000 | 19.93% | 0.00% |
| March 27, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 1353 | $231.67 | 18,652.0000 | 83,400,000 | 6.76% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 323 | $0.00 | 16,766.0000 | 83,400,000 | 1.96% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 86 | $245.14 | 16,680.0000 | 83,400,000 | 0.51% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 323 | $0.00 | 1,067.0000 | 83,400,000 | 23.24% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 356 | $0.00 | 16,277.0000 | 83,400,000 | 2.24% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 94 | $247.74 | 16,183.0000 | 83,400,000 | 0.58% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 354 | $0.00 | 16,537.0000 | 83,400,000 | 2.19% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 94 | $246.27 | 16,443.0000 | 83,400,000 | 0.57% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 356 | $0.00 | 1,744.0000 | 83,400,000 | 16.95% | 0.00% |
| Feb. 7, 2025 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 354 | $0.00 | 1,390.0000 | 83,400,000 | 20.30% | 0.00% |
| Aug. 5, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | S | Common Stock | 2245 | $229.79 | 25,769.0000 | 83,900,000 | 8.01% | 0.00% |
| Aug. 5, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | S | Common Stock | 9848 | $228.95 | 15,921.0000 | 83,900,000 | 38.22% | 0.01% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 7697 | $0.00 | 31,313.0000 | 83,900,000 | 32.59% | 0.01% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 3299 | $216.57 | 28,014.0000 | 83,900,000 | 10.54% | 0.00% |
| March 27, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 7697 | $0.00 | 2,100.0000 | 83,900,000 | 78.56% | 0.01% |
| Feb. 11, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 324 | $0.00 | 23,703.0000 | 83,900,000 | 1.39% | 0.00% |
| Feb. 12, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 87 | $227.45 | 23,616.0000 | 83,900,000 | 0.37% | 0.00% |
| Feb. 11, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 324 | $0.00 | 9,797.0000 | 83,900,000 | 3.20% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 353 | $0.00 | 23,473.0000 | 83,900,000 | 1.53% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 94 | $223.71 | 23,379.0000 | 83,900,000 | 0.40% | 0.00% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | A | Restricted Stock Unit | 1070 | $0.00 | 10,474.0000 | 83,900,000 | 11.38% | 0.00% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | A | Non-qualified Stock Options | 3300 | $0.00 | 3,300.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 353 | $0.00 | 10,121.0000 | 83,900,000 | 3.37% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 331 | $0.00 | 23,209.0000 | 83,900,000 | 1.45% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 89 | $221.54 | 23,120.0000 | 83,900,000 | 0.38% | 0.00% |
| Feb. 2, 2024 | LABCORP HOLDINGS INC. | $LH | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 331 | $0.00 | 9,404.0000 | 83,900,000 | 3.40% | 0.00% |